Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Med Sci 2019; 16(6):882-892. doi:10.7150/ijms.30082 This issue Cite

Research Paper

Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood

Sun-Yeong Gwon1,3, Hae Min Lee2, Ki-Jong Rhee3, Ho Joong Sung1,2✉

1. Department of Biomedical Laboratory Science, College of Health Science, Eulji University, Seongnam-si, Gyeonggi-do, 13135, Republic of Korea
2. Department of Senior Healthcare, BK21 plus Program, Graduated School, Eulji University, Daejeon, 34824, Republic of Korea
3. Department of Biomedical Laboratory Science, College of Health Sciences, Yonsei University at Wonju, Wonju, Gangwon-do 26493

✉ Corresponding author: Tel.: +82-31-740-7108; Fax: +82-31-740-7425; E-mail: hjsungac.kr

Citation:
Gwon SY, Lee HM, Rhee KJ, Sung HJ. Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood. Int J Med Sci 2019; 16(6):882-892. doi:10.7150/ijms.30082. https://www.medsci.org/v16p0882.htm
Other styles

File import instruction

Abstract

Cardiovascular disease (CVD) is highly fatal, and 80 percent of the mortality is attributed to heart attack and stroke. Atherosclerosis is a disease that increases a patient's risk to CVD and is characterized by atheroma formed by immune cells, lipids, and smooth muscle cells. When an atherosclerotic lesion grows and blocks blood vessels or when an atheroma ruptures and blocks blood vessels by embolism, sudden angina, or stroke can occur. It is therefore important to diagnose atherosclerosis early and prevent its progression to more severe disease. Although myeloperoxidase, plasma fibrinogen, cardiac troponin-I, and C-reactive protein have been considered as diagnostic markers for multiple cardiac risks, specific biomarkers for atherosclerosis have not been clearly determined yet. Particularly, reliable biomarkers for the diagnosis of atherosclerosis using whole blood are not yet available. In this study, we screened potential biomarker genes and proteins from whole blood of apolipoprotein E knockout (ApoE-/-) mice maintained on a Western diet, by comparing them to ApoE+/+ mice. We used whole blood for microarray and proteome array. Candidate genes and proteins identified from each method were confirmed with quantitative real-time PCR and ELISA. Based on our data, we speculate that Lilrb4a, n-R5s136, and IL-5 are potential targets that can be developed into novel biomarkers of atherosclerosis. Our study contributes to the diagnosis of atherosclerosis using whole blood in clinical settings.

Keywords: Atherosclerosis, ApoE knockout, microarray, proteome array, biomarker

Citation styles

APA
Gwon, S.Y., Lee, H.M., Rhee, K.J., Sung, H.J. (2019). Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood. International Journal of Medical Sciences, 16(6), 882-892. https://doi.org/10.7150/ijms.30082.

ACS
Gwon, S.Y.; Lee, H.M.; Rhee, K.J.; Sung, H.J. Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood. Int. J. Med. Sci. 2019, 16 (6), 882-892. DOI: 10.7150/ijms.30082.

NLM
Gwon SY, Lee HM, Rhee KJ, Sung HJ. Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood. Int J Med Sci 2019; 16(6):882-892. doi:10.7150/ijms.30082. https://www.medsci.org/v16p0882.htm

CSE
Gwon SY, Lee HM, Rhee KJ, Sung HJ. 2019. Microarray and proteome array in an atherosclerosis mouse model for identification of biomarkers in whole blood. Int J Med Sci. 16(6):882-892.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use